Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
نویسندگان
چکیده
منابع مشابه
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
Traditional antidepressants require many weeks to reveal their therapeutic effects. However, the widely replicated observation that a single subanesthetic dose of the N-methyl-D-aspartate glutamate receptor antagonist ketamine produced meaningful clinical improvement within hours, suggested that rapid-acting antidepressants might be possible. The ketamine studies stimulated a new generation of ...
متن کامل“Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity”
Since the emergence of Miltown in the 1950’s, through the development of popular drugs such as Librium and Valium, and presently with the SSRIs best exemplified by Prosac, antidepressants have been viable therapies for many with mood disorders and especially depression. Moreover, since World War II, there has been a virtual explosion in the prescription and use of such drugs. Unfortunately, no ...
متن کاملPersonalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
Major depressive disorder (MDD) is a chronic condition that affects one in six adults in the US during their lifetime. The current practice of antidepressant medication prescription is a trial-and-error process. Additionally, over a third of patients with MDD fail to respond to two or more antidepressant treatments. There are no valid clinical markers to personalize currently available antidepr...
متن کاملCannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.
Cannabidiol (CBD), the main non-psychotomimetic component of marihuana, exhibits anxiolytic-like properties in many behavioural tests, although its potential for treating major depression has been poorly explored. Moreover, the mechanism of action of CBD remains unclear. Herein, we have evaluated the effects of CBD following acute and chronic administration in the olfactory bulbectomy mouse mod...
متن کاملGlutamatergic neurotransmission in Alzheimer's disease.
The studies described here provide convincing evidence of glutamatergic deafferentation in Alzheimer's disease. This deafferentation is presumed to represent the biochemical correlate of pyramidal neuron dysfunction in the disorder. In addition, there is a growing consensus of opinion that there is no widespread depletion of glutamate NMDA receptors in Alzheimer's disease. The significance of g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Neuropsychopharmacology
سال: 2018
ISSN: 1461-1457,1469-5111
DOI: 10.1093/ijnp/pyy094